StockNews.com started coverage on shares of Insulet (NASDAQ:PODD – Get Rating) in a research note issued to investors on Thursday morning. The brokerage issued a hold rating on the medical instruments supplier’s stock. Several other research analysts have also weighed in on PODD. Stifel Nicolaus upped their target price on shares of Insulet from $300.00 […]